Adicet Bio, Inc. Share Price
ACETAdicet Bio, Inc. Stock Performance
Open $6.61 | Prev. Close $6.89 | Circuit Range N/A |
Day Range $6.61 - $6.99 | Year Range $0.45 - $8.83 | Volume 26,759 |
Average Traded $6.87 |
Adicet Bio, Inc. Share Price Chart
About Adicet Bio, Inc.
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Adicet Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $6.61 | $6.96 | +8.24% |
05-Feb-26 | $7.25 | $6.43 | -14.20% |
04-Feb-26 | $7.71 | $7.50 | -2.85% |
03-Feb-26 | $8.02 | $7.72 | -2.89% |
02-Feb-26 | $7.91 | $7.95 | -0.25% |
30-Jan-26 | $8.27 | $7.97 | -5.79% |
29-Jan-26 | $8.43 | $8.46 | +0.12% |